EU decides on Moderna’s COVID-19 injection for younger children in two months – Community News
Covid-19

EU decides on Moderna’s COVID-19 injection for younger children in two months

Vials containing the Moderna COVID-19 vaccine are on display at Apotex pharmaceutical company in Toronto, Ontario, Canada on April 13, 2021. REUTERS/Carlos Osorio

Nov. 10 (Reuters) – The European Union drug regulator expects to decide in about two months whether to allow use of Moderna’s (MRNA.O) COVID-19 vaccine in children ages six to 11, it said Wednesday, after the US drug manufacturer asked for approval.

“The current timeline for evaluation provides for advice in approximately 2 months, unless additional information or analysis is needed,” the European Medicines Agency (EMA) said in a statement.

Moderna said on Tuesday it had applied for European authorization to use a 50 microgram dose of its injection in the 6-11 age group, weeks after it delayed a similar application to US regulators. read more

The company had said in October that the vaccine elicited a strong immune response in children in that age group.

The European Union had approved the vaccine in July for use in teenagers ages 12 to 17, but several countries, including Sweden, have discontinued use for people aged 30 or younger due to rare heart-related side effects. read more

Reporting by Pushkala Aripaka in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.

About the author

Rakesh

Add Comment

Click here to post a comment